Literature DB >> 25044380

Failure analysis of clinical trials to test the amyloid hypothesis.

Bradley T Hyman1, Peter Sorger.   

Abstract

Mesh：

Year:  2014        PMID： 25044380     DOI： 10.1002/ana.24227

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  6 in total

Review 1.  No quiet surrender: molecular guardians in multiple sclerosis brain.

Authors:  Lawrence Steinman
Journal:  J Clin Invest       Date:  2015-04-01       Impact factor: 14.808

2.  Re-Engineering Alzheimer Clinical Trials: Global Alzheimer's Platform Network.

Authors:  J Cummings; P Aisen; R Barton; J Bork; R Doody; J Dwyer; J C Egan; H Feldman; D Lappin; L Truyen; S Salloway; R Sperling; G Vradenburg
Journal:  J Prev Alzheimers Dis       Date:  2016-03-04

3.  Few Structural Brain Changes Associated With Moderate-Intensity Interval Training and Low-Intensity Continuous Training in a Randomized Trial of Fitness and Older Adults.

Authors:  Renée Martin-Willett; Jarrod E Ellingson; Jill Fries; Timothy Helmuth; Hollis Karoly; Gregory Giordano; Vince D Calhoun; Angela D Bryan
Journal:  J Aging Phys Act       Date:  2020-12-02       Impact factor: 2.109

4.  Finding chemopreventatives to reduce amyloid beta in yeast.

Authors:  Ian G Macreadie; Costa Arvanitis; Prashant Bharadwaj
Journal:  Neural Regen Res       Date:  2016-02       Impact factor: 5.135

Review 5.  Oxidant/Antioxidant Imbalance in Alzheimer's Disease: Therapeutic and Diagnostic Prospects.

Authors:  Joanna Wojsiat; Katarzyna Marta Zoltowska; Katarzyna Laskowska-Kaszub; Urszula Wojda
Journal:  Oxid Med Cell Longev       Date:  2018-01-31       Impact factor: 6.543

6.  Systematic in silico analysis of clinically tested drugs for reducing amyloid-beta plaque accumulation in Alzheimer's disease.

Authors:  Kumpal Madrasi; Raibatak Das; Hafiz Mohmmadabdul; Lin Lin; Bradley T Hyman; Douglas A Lauffenburger; Mark W Albers; Robert A Rissman; John M Burke; Joshua F Apgar; Lucia Wille; Lore Gruenbaum; Fei Hua
Journal:  Alzheimers Dement       Date:  2021-05-02       Impact factor: 21.566
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.